Silvi Materials is proud to announce the official launch of the Silvi Foundation, a nonprofit organization dedicated to advancing research in Alzheimer’s, dementia, ALS, Parkinson’s, and related neurodegenerative diseases.

The Foundation’s launch includes an inaugural $100,000 grant to the Institute for Neurodegenerative Diseases (IND) to support innovative blood-based biomarker research aimed at improving early detection and diagnosis.

Silvi Foundation awards its inaugural $100,000 research grant to the Institute for Neurodegenerative Diseases (IND).

A Commitment Rooted in Family

The Silvi Foundation was created in honor of company founder Larry Silvi Sr. and his wife Rose, both of whom battled Alzheimer’s disease. Their experience profoundly impacted the Silvi family and shaped a long-term commitment to supporting meaningful scientific advancement.

Now in its third generation of family leadership, Silvi Materials continues to operate with the same principles that have guided the company for decades: responsibility, accountability, and service to the communities it supports.

The Silvi Foundation extends those values beyond the business by investing in research and initiatives that have the potential to improve outcomes for patients and families.

Supporting Early Detection and Scientific Progress

IND’s research focuses on identifying blood-based biomarkers that may indicate disease risk and progression before symptoms appear. Early detection is widely recognized as a critical component in advancing treatment strategies and strengthening clinical research.

The Silvi Foundation’s support will help fund laboratory equipment, research personnel, biorepository development, and continued biomarker analysis.

Through the Silvi Foundation, the Silvi family and Silvi Materials are committed to building long-term partnerships that contribute to meaningful progress in the fight against neurodegenerative disease.

Learn more about the Silvi Foundation and how you can support its mission at https://silvifoundation.org/.